160 related articles for article (PubMed ID: 31722234)
1. Matrine alleviates astrogliosis through sphingosine 1-phosphate signaling in experimental autoimmune encephalomyelitis.
Ma W; Zhang M; Liu S; Wang M; Shi Y; Yang T; Li X; Zhu L
Neurosci Lett; 2020 Jan; 715():134599. PubMed ID: 31722234
[TBL] [Abstract][Full Text] [Related]
2. Matrine Treatment Blocks NogoA-Induced Neural Inhibitory Signaling Pathway in Ongoing Experimental Autoimmune Encephalomyelitis.
Kan QC; Zhang HJ; Zhang Y; Li X; Xu YM; Thome R; Zhang ML; Liu N; Chu YJ; Zhang GX; Zhu L
Mol Neurobiol; 2017 Dec; 54(10):8404-8418. PubMed ID: 27933584
[TBL] [Abstract][Full Text] [Related]
3. Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Kan QC; Zhang S; Xu YM; Zhang GX; Zhu L
Neurosci Lett; 2014 Feb; 560():92-7. PubMed ID: 24368216
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
Chu Y; Jing Y; Zhao X; Wang M; Zhang M; Ma R; Ma W; Lv Y; Zhu L
J Neuroimmunol; 2021 Mar; 352():577480. PubMed ID: 33493985
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Zhu L; Pan QX; Zhang XJ; Xu YM; Chu YJ; Liu N; Lv P; Zhang GX; Kan QC
Exp Mol Pathol; 2016 Apr; 100(2):337-43. PubMed ID: 26681653
[TBL] [Abstract][Full Text] [Related]
6. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis.
Liu N; Kan QC; Zhang XJ; Xv YM; Zhang S; Zhang GX; Zhu L
Exp Mol Pathol; 2014 Dec; 97(3):470-6. PubMed ID: 25303900
[TBL] [Abstract][Full Text] [Related]
8. Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
Zhao X; Zhang X; Lv Y; Xu Y; Li M; Pan Q; Chu Y; Liu N; Zhang GX; Zhu L
Immunol Lett; 2016 Oct; 178():97-104. PubMed ID: 27562326
[TBL] [Abstract][Full Text] [Related]
9. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
10. Matrine protects neuro-axon from CNS inflammation-induced injury.
Kan QC; Lv P; Zhang XJ; Xu YM; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Feb; 98(1):124-30. PubMed ID: 25576296
[TBL] [Abstract][Full Text] [Related]
11. Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.
Chu YJ; Ma WD; Thome R; Ping JD; Liu FZ; Wang MR; Zhang ML; Zhang G; Zhu L
Front Immunol; 2020; 11():569530. PubMed ID: 33101289
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation.
Zhu Y; Qin Z; Gao J; Yang M; Qin Y; Shen T; Liu S
Mol Neurobiol; 2014 Dec; 50(3):733-43. PubMed ID: 24722820
[TBL] [Abstract][Full Text] [Related]
13. Matrine inhibits the Wnt3a/β-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis.
Ma R; Chu Y; Dou M; Jing Y; Zhao X; Li X; Li S; Zhang Y; Wang L; Zhu L
J Neuroimmunol; 2022 Jun; 367():577876. PubMed ID: 35489221
[TBL] [Abstract][Full Text] [Related]
14. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Choi JW; Gardell SE; Herr DR; Rivera R; Lee CW; Noguchi K; Teo ST; Yung YC; Lu M; Kennedy G; Chun J
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):751-6. PubMed ID: 21177428
[TBL] [Abstract][Full Text] [Related]
15. Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity.
Jing Y; Ma R; Chu Y; Dou M; Wang M; Li X; Zhu L
J Chem Neuroanat; 2021 Nov; 117():102004. PubMed ID: 34280490
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Zhang S; Kan QC; Xu Y; Zhang GX; Zhu L
Mediators Inflamm; 2013; 2013():736085. PubMed ID: 24194630
[TBL] [Abstract][Full Text] [Related]
17. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Kan QC; Zhu L; Liu N; Zhang GX
Immunol Res; 2013 May; 56(1):189-96. PubMed ID: 23549837
[TBL] [Abstract][Full Text] [Related]
18. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Garris CS; Wu L; Acharya S; Arac A; Blaho VA; Huang Y; Moon BS; Axtell RC; Ho PP; Steinberg GK; Lewis DB; Sobel RA; Han DK; Steinman L; Snyder MP; Hla T; Han MH
Nat Immunol; 2013 Nov; 14(11):1166-72. PubMed ID: 24076635
[TBL] [Abstract][Full Text] [Related]
19. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis.
Zhao X; Kan Q; Zhu L; Zhang GX
Am J Chin Med; 2011; 39(5):933-41. PubMed ID: 21905283
[TBL] [Abstract][Full Text] [Related]
20. The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway.
Luo J; Chen R; Zeng S; Yu J; Jiang G; Wang L; Qin X
Biochem Biophys Res Commun; 2017 Aug; 490(3):927-932. PubMed ID: 28655617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
